196 reports of this reaction
2.5% of all DEXMETHYLPHENIDATE HYDROCHLORIDE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for DEXMETHYLPHENIDATE HYDROCHLORIDE, manufactured by Novartis Pharmaceuticals Corporation. There are 196 FDA adverse event reports linking DEXMETHYLPHENIDATE HYDROCHLORIDE to NAUSEA. This represents approximately 2.5% of all 7,728 adverse event reports for this drug.
Patients taking DEXMETHYLPHENIDATE HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for DEXMETHYLPHENIDATE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for DEXMETHYLPHENIDATE HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 196 FDA reports for DEXMETHYLPHENIDATE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.5% of all adverse event reports for DEXMETHYLPHENIDATE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking DEXMETHYLPHENIDATE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.